Advertisement
Screener

EVOFEM BIOSCIENCES, INC. (EVFM) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1.9 / 5 stars · 29/78 Roast Me

EVOFEM BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

EVOFEM BIOSCIENCES, INC. (EVFM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 263.12 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-27.

Discontinued › Shareholders' Equity

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2023-04-27

  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-12-31 was 0.00 shares, a 100.00% decline year-over-year.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-09-30 was 5.40K shares, a 92.29% decline year-over-year.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-06-30 was 40.00K shares, a 84.48% decline year-over-year.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-03-31 was 217.72K shares, a 91.21% decline year-over-year.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 263.12K shares, a 91.80% decline from fiscal 2021.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 3.21M shares.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 400.72K shares, a 43.56% decline from fiscal 2014.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 710.03K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2022-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-27
5.40K shares
derived: sum of 2 quarters · filed 2023-04-27
45.40K shares
derived: sum of 3 quarters · filed 2023-04-27
263.12K shares
10-K · filed 2023-04-27
2022-09-305.40K shares
10-Q · filed 2023-01-06
45.40K shares
derived: sum of 2 quarters · filed 2023-01-06
263.12K shares
10-Q · filed 2023-01-06
345.12K shares
derived: sum of 4 quarters · filed 2023-01-06
2022-06-3040.00K shares
10-Q · filed 2022-08-12
257.72K shares
derived: sum of 2 quarters · filed 2022-08-12
339.72K shares
derived: sum of 3 quarters · filed 2022-08-12
409.72K shares
derived: sum of 4 quarters · filed 2022-08-12
2022-03-31217.72K shares
10-Q · filed 2022-05-10
299.72K shares
derived: sum of 2 quarters · filed 2022-05-10
369.72K shares
derived: sum of 3 quarters · filed 2022-05-10
627.44K shares
derived: sum of 4 quarters · filed 2022-08-12
2021-12-3182.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
152.00K shares
derived: sum of 2 quarters · filed 2022-03-10
409.72K shares
derived: sum of 3 quarters · filed 2022-08-12
3.21M shares
10-K · filed 2022-03-10
2021-09-3070.00K shares
10-Q · filed 2021-11-15
327.72K shares
derived: sum of 2 quarters · filed 2022-08-12
3.13M shares
10-Q · filed 2021-11-15
2021-06-30257.72K shares
10-Q · filed 2022-08-12
578.50K shares
10-Q · filed 2021-08-11
3.06M shares
10-Q · filed 2021-08-11
2021-03-312.48M shares
10-Q · filed 2021-05-06
2020-09-30631.20K shares
10-Q · filed 2021-11-15
1.40M shares
derived: sum of 2 quarters · filed 2021-11-15
2.87M shares
10-Q · filed 2021-11-15
2020-06-30767.00K shares
10-Q · filed 2021-08-11
2.24M shares
10-Q · filed 2021-08-11
2020-03-311.48M shares
10-Q · filed 2021-05-06
2019-09-30290.00K shares
10-Q · filed 2020-11-09
674.00K shares
derived: sum of 2 quarters · filed 2020-11-09
733.00K shares
10-Q · filed 2020-11-09
2019-06-30384.00K shares
10-Q · filed 2020-08-04
443.00K shares
10-Q · filed 2020-08-04
2019-03-3159.00K shares
10-Q · filed 2020-05-06
2018-09-301.15M shares
10-Q · filed 2019-11-07
1.28M shares
derived: sum of 2 quarters · filed 2019-11-07
4.42M shares
10-Q · filed 2019-11-07
4.72M shares
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30134.38K shares
10-Q · filed 2019-08-06
3.27M shares
10-Q · filed 2019-08-06
3.57M shares
derived: sum of 3 quarters · filed 2019-08-06
3.57M shares
derived: sum of 4 quarters · filed 2019-08-06
2018-03-313.14M shares
10-Q · filed 2018-08-02
3.14M shares
10-Q · filed 2019-05-07
3.44M shares
derived: sum of 2 quarters · filed 2019-05-07
3.44M shares
derived: sum of 3 quarters · filed 2019-05-07
3.44M shares
derived: sum of 4 quarters · filed 2019-05-07
2017-12-31301.07K shares
derived: 8-K/A 12 month − 10-Q 9 month · filed 2018-04-06
301.07K shares
derived: sum of 2 quarters · filed 2018-11-07
302.36K shares
derived: sum of 3 quarters · filed 2018-11-07
309.00K shares
8-K/A · filed 2018-04-06
2017-09-300.00 shares
10-Q · filed 2018-11-07
1.28K shares
derived: sum of 2 quarters · filed 2018-11-07
7.93K shares
10-Q · filed 2018-11-07
875.30K shares
10-Q · filed 2017-11-08
2017-06-301.28K shares
10-Q · filed 2018-08-02
7.93K shares
10-Q · filed 2018-08-02
875.30K shares
10-Q · filed 2017-08-10
2017-03-316.64K shares
10-Q · filed 2018-05-14
370.00K shares
10-Q · filed 2017-05-11
2016-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
406.36K shares
derived: sum of 2 quarters · filed 2016-11-10
563.86K shares
10-Q · filed 2016-11-10
563.86K shares
derived: sum of 4 quarters · filed 2016-11-10
2016-06-30406.36K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
563.86K shares
10-Q · filed 2016-08-11
563.86K shares
derived: sum of 3 quarters · filed 2016-08-11
608.97K shares
derived: sum of 4 quarters · filed 2016-08-11
2016-03-31157.50K shares
10-Q · filed 2016-05-12
157.50K shares
derived: sum of 2 quarters · filed 2016-05-12
202.62K shares
derived: sum of 3 quarters · filed 2016-05-12
343.25K shares
derived: sum of 4 quarters · filed 2016-05-12
2015-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
45.12K shares
derived: sum of 2 quarters · filed 2016-03-29
185.75K shares
derived: sum of 3 quarters · filed 2016-03-29
400.72K shares
10-K · filed 2016-03-29
2015-09-3045.12K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
185.75K shares
derived: sum of 2 quarters · filed 2015-11-12
400.72K shares
10-Q · filed 2015-11-12
2015-06-30140.63K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
355.60K shares
10-Q · filed 2015-08-13
2015-03-31214.97K shares
10-Q · filed 2015-05-14
2014-12-31710.03K shares
10-K · filed 2016-03-29
2013-12-310.00 shares
10-K · filed 2016-03-29